Skip to content

COULTREON BIOPHARMA

Active
Private limited company·Vervaardiging van geneesmiddelen· 1 yrs active
Gaston Geenslaan 3 ·3001 Leuven, Belgium
KBO/BCE: BE 1019.429.814
Watch Print / PDF
Belgian State Gazette acts: 0 of 6 read
Age1 yr
Connections6
Real estate1 parcel · 2,297 m²

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of COULTREON BIOPHARMA is 1.1% (low). The company has been active since 2025 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.

Based on State Gazette and CBE data.

Filing behaviour

From the deposit records, complete market-wide
No filing deadline can be computed
The statutory deadline is seven months after the close of the financial year, and that close is far from always 31 December. For this company we see no filed accounts and no founding deed stating the year end, so we compute no deadline and make no claim. This is expressly not a confirmation that anything was filed on time.
How we compute the deadline
We do not know this company's financial year end, so we compute no filing deadline.

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals
Young company
Founded in 2025, under 3 years, statistically higher risk.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
1.1% Low
0%0,5%1,5%4%10%≥25%
Young company +Higher-failure-rate sector +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

Annual accounts & ratios

Source: NBB
No annual accounts filed
We find no annual accounts filed with the National Bank for this company. Not every legal form has to file: sole traders, small non-profits and dormant companies generally publish no figures. If the company files later, the figures appear here automatically.

Directors

Directors & mandates

3 directors
6 of this company's 6 Belgian State Gazette acts have not been read yet. Appointments and resignations recorded in them are missing below: a director who resigned there may therefore still show here as sitting. See the acts under Publications.
Current directors & mandates
  • Lawrence Blatt
    Director
    State Gazette act 26030849 (02-03-2026)
    Current
    20-11-2025 → present
  • Vuldex Consulting BVLegal entity
    Director· perm. rep.: Marie De Vulder
    State Gazette act 25151961 (01-12-2025)
    Current
    01-06-2025 → present
  • Pierre Raboisson BVLegal entity
    Managing director· perm. rep.: Pierre Raboisson
    State Gazette act 25151961 (01-12-2025)
    Current
    01-04-2025 → present
    2 events
    • 01-06-2025 Appointed· Managing director
    • 01-04-2025 Appointed· Director
Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.

Insolvency mandates

No insolvency mandates (liquidators, administrators) on record for this company.

Legal Structure

NACE primary Vervaardiging van geneesmiddelen(21201)
Legal form Private limited company(610)
Incorporation30-01-2025
StatusActive
Postal code3001

Structure & network

Connections & network

6 connected companies
Metaptys, Shared address MMetaptysMolecular Plasma Group, Shared address MPMolecularPlasma GroupPartiX, Shared address PPartiXQUOMAK, Shared address QQUOMAKReWind Therapeutics, Shared address RTReWindTherapeuticsTavira Therapeutics, Shared address TTTaviraTherapeuticsCOULTREON BIOPHARMA COULTREONBIOPHARMA1019.429.814
Shared address / shareholder
Network connections
Metaptys
Shared address
→
→
PartiX
Shared address
→
QUOMAK
Shared address
→
Show 2 more network connections
ReWind Therapeutics
Shared address
→
Tavira Therapeutics
Shared address
→
Connections derived from shared directors, addresses, shareholders and group structure in the Belgian State Gazette.

Locations & real estate

Registered office

on the map · from the address register
exact location from the address register On OpenStreetMap
13 companies at this address See who is registered here

Establishment units

1 location
Coultreon Biopharma
Gaston Geenslaan 3, 3001 LeuvenVervaardiging van geneeskrachtige kruidentheeën
since 20252.371.509.448
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area2,297 m²
Buildings1
Building footprint1,484 m²
Volume (LiDAR)38 m³
Tallest building2.6 m

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
24040B0218/00V002 Flanders 2,297 m² 1 · 1,484 m² 2.6 m
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgisch Staatsblad · acts

7 acts
Company purpose
De private stichting wordt opgericht ter verwezenlijking van het volgend belangeloos doel: het bevorderen van een stabiel aandeelhouderschap van Coultreon Biopharma, met het oog op een efficiënte en eenvoudige besluitvorming binnen Coultreon Biopharma (waarvan de Aandelen worden gecertificeerd overeenkomstig de voorwaarden zoals bepaald in de Administratievoorwaarden en de Aandeelhoudersovereenkomt). De private stichting beoogt met deze structuur een duurzame scheiding tot stand te brengen tussen de economische gerechtigheid tot de Aandelen en de uitoefening van de daaraan verbonden zeggenschapsrechten. De private stichting zal fungeren als administratiekantoor van de Aandelen van Coultreon Biopharma.
Per act of 04-08-2026
All acts · 7 updated 13 days ago
2026
04-08-2026 Act object · Notarial deed · Incorporation · Founder Open-capture extraction
  • Act object: OPRICHTING · Stichting Administratiekantoor Coultreon
  • Publication: 04/08/2026 · Stichting Administratiekantoor Coultreon
  • Filing: 31-07-2026 · Stichting Administratiekantoor Coultreon
  • Notarial deed: 31-07-2026 · Stichting Administratiekantoor Coultreon
  • Incorporation: 31-07-2026 · Stichting Administratiekantoor Coultreon
  • Founder · COULTREON BIOPHARMA
  • Purpose: De private stichting wordt opgericht ter verwezenlijking van het volgend belangeloos doel: het bevorderen van een stabiel aandeelhouderschap van Coultreon Biopharma, met het oog op een efficiënte en eenvoudige besluitvorming binnen Coultreon Biopharma (waarvan de Aandelen worden gecertificeerd overeenkomstig de voorwaarden zoals bepaald in de Administratievoorwaarden en de Aandeelhoudersovereenkomt). De private stichting beoogt met deze structuur een duurzame scheiding tot stand te brengen tussen de economische gerechtigheid tot de Aandelen en de uitoefening van de daaraan verbonden zeggenschapsrechten. De private stichting zal fungeren als administratiekantoor van de Aandelen van Coultreon Biopharma. · Stichting Administratiekantoor Coultreon
  • First fiscal year: 31-12-2027 · Stichting Administratiekantoor Coultreon
  • Officer appointment: role: bestuurder, term: onbepaalde duur, start_date: 2026-07-31 · Pierre Raboisson BV
  • Permanent representative · Pierre RABOISSON
  • Officer appointment: role: bestuurder, term: onbepaalde duur, start_date: 2026-07-31 · Vuldex Consulting BV
  • Permanent representative · Marie DE VULDER
  • Officer appointment: role: bestuurder, term: onbepaalde duur, start_date: 2026-07-31 · SKJ Consult BV
  • Permanent representative · Guy PEETERS
  • Mandate compensation: onbezoldigd · Pierre Raboisson BV
  • Mandate compensation: onbezoldigd · Vuldex Consulting BV
  • Mandate compensation: onbezoldigd · SKJ Consult BV
  • Filing representative: vervulling van de formaliteiten bij het rechtspersonenregister alsook bij een ondernemingsloket met het oog op de inschrijving van de gegevens van de private stichting in de Kruispuntbank van Ondernemingen · Osborne Clarke BV
  • Filing representative: het verkrijgen van de rechtspersoonlijkheid van de vereniging en de publicatie van de statuten in de Bijlagen bij het Belgisch Staatsblad · Berquin Notarissen
Summary: Act object · Notarial deed · Incorporation · Founder
05-05-2026 Change in the board of directors Director changes·Matthieu DERYNCK
Notary: Matthieu DERYNCK · BrusselFirm: Van Halteren Notarissen
20-04-2026 Publication in the Belgian Official Gazette, Minor change Minor change
Summary: v3.2
02-03-2026 2 directors appointed, 1 resigning Director changes
  • Lawrence Blatt, Bestuurder
  • SKJ Consult BV, Bestuurder
  • Vuldex Consulting BV, Bestuurder
Summary: v3.2
2025
01-12-2025 2 directors appointed Director changes
  • Pierre Raboisson, Gedelegeerd bestuurder
  • Marie De Vulder, Bestuurder
Summary: v3.2
17-06-2025 Pierre Raboisson appointed as director Director changes
  • Pierre Raboisson, Bestuurder
Summary: v3.2
03-02-2025 Incorporation of a new BV Incorporation
Summary: oprichting

Analysis

Credit advice

verdict per customer and amount

May this customer buy amount X on invoice? Enter the amount and the payment term. This page computes a GREEN, AMBER or RED verdict from them, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Same sector and region
We hold no filed accounts for this company, so a size comparison is not possible. These companies share only the sector and the region. We hold annual accounts for 26 of the 148 companies in this sector.

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Vervaardiging van geneesmiddelen21201Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied72109Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied72109
Primary activity highlighted.
Names & trade names
Legal nameNL COULTREON BIOPHARMA
Legal nameNL ONCO3R Therapeutics
AbbreviationNL COULTREON
Registered office
Gaston Geenslaan 3
3001 Leuven, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.